Some takeaways:

  • Metaanalyses are very cool.
  • Putting too much emphasis on costly large-scale randomized controlled trials gives an advantage to new and expensive drugs over established out-of-patent drugs.
  • Ivermectin should be approved both as a treatment and as a preventative for COVID-19 (but see post #1099).